William McKee, Director at Assertio Therapeutics, Inc (ASRT), sold 10,000 shares at $4.07 ($41K) on 2018-12-14, disclosed to the SEC on 2018-12-17.
Scheduled sale ($41k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CCCC | BUY | 2020-10-06 | $100K | — | Filing → |
| ASRT | SELL | 2019-05-09 | $59K | — | Filing → |
| AUXL | SELL | 2014-12-08 | $612K | — | Filing → |